PKC Substrate Makes Its MARCKS on Dendritic Spines
MARCKS, the myristoylated alanine-rich C kinase substrate, has been studied in non-neuronal cells for years as a regulator of...
6390 RESULTS
Sort By:
MARCKS, the myristoylated alanine-rich C kinase substrate, has been studied in non-neuronal cells for years as a regulator of...
Microglia don’t start the fire in Alzheimer disease brain, but they certainly can heat things up when it comes to...
The use of gene expression profiling to characterize Alzheimer disease pathology has, unsurprisingly, focused on...
Tom Fagan Interviews Rudy Tanzi and Lars Bertram
One of the earliest problems many Alzheimer patients experience is...
One of the great hopes for stem cells is that they might be capable of...
The New York-based biopharmaceutical company Axonyx announced Tuesday that its experimental acetyl cholinesterase inhibitor drug...
No longer at the top of your game? Feel like age is catching up to you? Don’t trash that treadmill yet...
Among the strategies currently being pursued for treatment of Alzheimer disease (AD), inhibiting...
Embryonic or pluripotent stem cells remain one of the best hopes for replacing the lost or damaged tissue that can lead to neurodegenerative diseases...
For years, geneticists studying tau have been stymied by the conspicuous absence of...
Hunting for clues to the function of the Parkinson gene DJ-1, researchers have garnered new leads by once again...
Though most neurodegenerative diseases affect different parts of the brain, the presence of...
In August 2005, a group of researchers from inside and outside the field of Alzheimer disease met in Bar Harbor, Maine, with foundation and NIH representatives for two days of presentations and discussion at the fifth annual workshop on Enabling Technologies for Alzheimer's Disease Research.
It is widely accepted that at least a fraction of APP is actively transported along the axon to the nerve terminal and does not return to the cell body.
No filters selected